Why stimulants are the answer for most of us
Last week I was in a giant tent in the grounds of London Business School to hear various CEO’s (amongst others - WPP’s Sir Martin Sorrell, Lloyds’ Antonio Horta-Osorio, 3M’s George Buckley) on the subject of innovation. The unseasonal high winds meant that at some points the flapping of the tent added a sense of danger and was so loud you couldn’t hear the speakers. But when I could I was struck by George Buckley describing how naturally innovation came to 3M.

Later and in contrast another speaker, Nick Hughes, previously with Vodafone and developer of the Kenyan mobile money platform M-Pesa told us that he could only get traction on the idea after attracting £1m of external financing. This funded a prototype which enabled the project to move through the system.
I suspect there are two sorts of large companies in the world; First there are a very limited number (4 or 5; maybe 3M, Google, IBM, Apple…..) with innovation DNA who have the ability to reproduce in different forms naturally and secondly, all other companies. These are the leviathans for whom innovation is an alien activity. They require a dose of corporate Viagra to get them going. An injection of something different – a cocktail of freshness and bravery from outside their organisation.
So there’s a new way of looking at innovation – if your organization doesn’t do it naturally then what’s your ‘stimulus’. You never know it might be fun!